On March 23, 2026, Core Laboratories Inc. (NYSE: CLB) announced a revision to its earnings guidance for the first quarter of 2026, attributing the changes to the ongoing geopolitical conflict in the Middle East. The company indicated that regional instability has led to client-driven project delays, travel constraints, and supply chain disruptions, which are expected to negatively impact its financial results for the quarter.

Core Lab's revised revenue guidance for Q1 2026 is projected to range between $119 million and $123 million, with operating income, excluding items, expected to fall between $5.7 million and $7.1 million. The company anticipates earnings per share, excluding items, to be between $0.05 and $0.07. This marks a significant downward adjustment from previous forecasts made on February 4, 2026.

The company emphasized that the safety and security of its employees remain a top priority as it navigates the challenges posed by the conflict. Core Lab is actively working with clients and local teams to manage operations and mitigate the impacts on project execution. The effects of the conflict have been particularly pronounced in the Reservoir Description segment, which relies heavily on predictable field access and laboratory operations. In contrast, the Production Enhancement segment has experienced comparatively less disruption, although some shipments of products have been delayed.

Core Laboratories plans to provide further updates as the situation evolves and will hold a conference call to discuss its first quarter earnings on April 30, 2026, at 7:30 a.m. CDT. The company is committed to keeping stakeholders informed about the ongoing developments and their potential impact on its operations and financial performance.



Press Release distribution
National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.